'Reversible' Blood Thinner May Cut Bleeding Risk (IMAGE)
Caption
Researchers have developed an antibody that prevents blood clots without causing bleeding, a risk associated with current anticoagulant drugs. This material relates to a paper that appeared in the Aug. 24, 2016 issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by T. David at University of California, San Francisco in San Francisco, CA, and colleagues was titled, "Factor XIa-specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis."
Credit
Chris Bickel / <i>Science Translational Medicine</i> (2016)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content